Daiichi Sankyo Names Nakayama To Succeed Takashi Shoda As CEO
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo named Joji Nakayama to be president and CEO of the firm, succeeding Takashi Shoda, who is to become chairman